Gregory K. Bell, Andrew Tepperman, and Justin Ho contributed a chapter to Global Arbitration Review’s The Guide to Damages in International Arbitration. Their chapter, entitled “Damages in Life Sciences Arbitrations,” covers disputes in the life sciences sector, with a focus on the biopharmaceutical industry. The authors outline some of the main types of disputes that are heard in life sciences arbitrations and discuss some of the life sciences-specific aspects of common analyses that are used to determine damages in these types of disputes.
To read more, click the link below.
Regulatory changes present new sources of renewable energy disputes
Despite the continuing effect of the pandemic on financing, investment and construction in many countries, the Americas continued to see substantial additions...